Pfizer, Merck strike deal to develop cancer tumor treatment By: MarketWatch November 17, 2014 at 04:18 AM EST Germany’s Merck will get $850 million upfront to work on the product, but Pfizer downgrades its 2014 EPS view as a result of the transaction. Read More >> Related Stocks: Pfizer